Retrieve available abstracts of 11 articles: HTML format
Single Articles
January 2025
ALLEN-PHILBEY K, Stephenson S, Doody G, MacDougall A, et al Effects of cladribine on intrathecal and peripheral B and plasma cells.
Clin Exp Immunol. 2025;219:uxae116. PubMedAbstract available
STEGNJAIC G, Nikolovski N, Stanisavljevic S, Lazarevic M, et al Immunomodulatory effects of HYCO-3, a dual action CO-releaser/Nrf2 activator.
Clin Exp Immunol. 2025;219:uxae100. PubMedAbstract available
SMITH KJ, Lim Z, Vermeren S, Miron VE, et al Proteomic analysis reveals dysregulation of peripheral blood neutrophils in
patients with Multiple Sclerosis.
Clin Exp Immunol. 2025 Jan 16:uxae115. doi: 10.1093. PubMedAbstract available
ZAGRODNIK JL, Blandford SN, Fudge NJ, Arsenault ST, et al Investigating T cell-derived extracellular vesicles as biomarkers of disease
activity, axonal injury, and disability in multiple sclerosis.
Clin Exp Immunol. 2025 Jan 11:uxaf003. doi: 10.1093. PubMedAbstract available
November 2024
LI J, Wu Z, Wu Y, Hu X, et al IL-22, a vital cytokine in autoimmune diseases.
Clin Exp Immunol. 2024;218:242-263. PubMedAbstract available
April 2024
MARTIN-GUTIERREZ L, Waddington KE, Maggio A, Coelewij L, et al Dysregulated Lipid Metabolism Networks Modulate T-cell Function in People with
Relapsing Remitting Multiple Sclerosis.
Clin Exp Immunol. 2024 Apr 16:uxae032. doi: 10.1093. PubMedAbstract available
January 2024
KELLY AJ, Long A Targeting T-cell integrins in autoimmune and inflammatory diseases.
Clin Exp Immunol. 2024;215:15-26. PubMedAbstract available
December 2023
JARVINEN E, Suomi F, Stewart JB, Guala D, et al Cultured lymphocytes' mitochondrial genome integrity is not altered by
cladribine.
Clin Exp Immunol. 2023;214:304-313. PubMedAbstract available
July 2023
VAN NOORT JM, Baker D, Kipp M, Amor S, et al The pathogenesis of multiple sclerosis: a series of unfortunate events.
Clin Exp Immunol. 2023 Jul 6:uxad075. doi: 10.1093. PubMedAbstract available
April 2023
COSSU D, Yokoyama K, Sakanishi T, Sechi LA, et al Bacillus Calmette-Guerin Tokyo-172 vaccine provides age-related neuroprotection
in actively induced and spontaneous experimental autoimmune encephalomyelitis
models.
Clin Exp Immunol. 2023;212:70-80. PubMedAbstract available
March 2023
OLSON KE, Mosley RL, Gendelman HE The potential for treg-enhancing therapies in nervous system pathologies.
Clin Exp Immunol. 2023;211:108-121. PubMedAbstract available